Geoffrey Spolyar

    • ERYTECH – $144 Million IPO 

    • ZELTIQ Aesthetics to Sell to Allergan for $2.5 Billion 

    • Cooley Advises on Nightstar + NuCana IPOs 

    • Jazz Pharmaceuticals Acquisition of Redx Pharma's pan-RAF Inhibitor Program Valued up to $206 Million 

    • X4 Pharmaceuticals in its Exclusive License Agreement with Abbisko Therapeutics 

    • GENFIT SA in its Licensing and Collaboration Agreement with Terns Pharmaceuticals 

    • Innate Pharma - $79 Million IPO 

    • Therachon Sells to Pfizer for up to $810 Million 

    • AN2 Therapeutics in its Exclusive License Agreement with Brii Biosciences 

    • Celularity to Go Public Through SPAC Merger